Nested within the SwissPrEPared Program, the "SwissPrEPared Study" - a large, multicentric, nation-wide cohort study - aims to longitudinally follow individuals asking for PrEP prescription over a period of 3 years.
Age range
16 Years – 120 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of individuals asking for PrEP
Timeframe: 10 years
Proportion of individuals qualifying for PrEP according to current guidelines
Timeframe: 10 years
PrEP regime used (daily, intermittent, on-demand)
Timeframe: 10 years
Mode of drug supply (pharmacy versus online)
Timeframe: 10 years
Adherence rates to programme
Timeframe: 10 years
Adherence rates to PrEP
Timeframe: 10 years
Occurrence of side effects
Timeframe: 10 years
Prevalence of HIV
Timeframe: 10 years
Incidence of HIV
Timeframe: 10 years
Prevalence of other STIs (syphilis, hepatitis B, hepatitis C, gonorrhoea, chlamydia, mycoplasma genitalium)
Timeframe: 10 years
Incidence of other STIs (syphilis, hepatitis B, hepatitis C, gonorrhoea, chlamydia, mycoplasma genitalium)
Timeframe: 10 years